VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Stock Surges 200%: Compass Pathways Submits NDA for COMP360 Psilocybin Therapy, Poised to Revolutionize Depression Treatment
Stock Surges 200%: Compass Pathways Submits NDA for COMP360 Psilocybin Therapy, Poised to Revolutionize Depression Treatment
Jun 04, 2026 21:53 CST Updated Jun 05, 01:22
Share:
